AREMED

This brand name is authorized in Albania, Cyprus, Hong Kong, Croatia, Malta, New Zealand, Singapore

Active ingredients

The drug AREMED contains one active pharmaceutical ingredient (API):

1 Anastrozole UNII 2Z07MYW1AZ - ANASTROZOLE

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. Read about Anastrozole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AREMED Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BG03	Anastrozole	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 444/110
Country: HK	Department of Health Drug Office	Identifier(s): 59104
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-515382101
Country: MT	Medicines Authority	Identifier(s): AA084/07401
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13559
Country: SG	Health Sciences Authority	Identifier(s): 14001P